New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
08:32 EDTCBPOChina Biologic announces favorable resolution to title dispute
China Biologic announced that the company has learned that the pending claim in the High Court of Hong Kong against Siu Ling Chan, an individual shareholder of the company, and her spouse, Tung Lam, had been withdrawn with Court approval. The claim was originally filed by a group of individuals against the title of certain shares of the company's common stock held by Chan and Lin Ling Li, a formal individual shareholder of the company. The company understands that the plaintiffs have reached settlement agreements with all defendants, including Chan and her spouse, with respect to the claim, and the claim against other defendants, Li and her spouse, had also previously been withdrawn with Court approval. The withdrawal of the claim against Chan and her spouse with Court approval thus represents a final conclusion to the title dispute in respect of certain shares of the Company's common stock held by Chan and Li.
News For CBPO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 17, 2014
08:31 EDTCBPOChina Biologic receives approval for commercial manufacturing of prothrombin
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use